Tue, March 25, 2025
Mon, March 24, 2025
Sun, March 23, 2025
Sat, March 22, 2025
Fri, March 21, 2025
Thu, March 20, 2025
Wed, March 19, 2025
Tue, March 18, 2025
Mon, March 17, 2025

Tianjin Lisheng Pharmaceutical Reports 2024 Financial Results and Dividend Proposal


  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. 024-financial-results-and-dividend-proposal.html
  Print publication without navigation Published in Business and Finance on by TipRanks

Tianjin Development Holdings ( ($HK:0882) ) has shared an update. Tianjin Development Holdings Limited announced the audited financial results for

Tianjin Lisheng Pharmaceutical Co., Ltd. has announced its financial results for the year 2024, revealing a significant increase in both revenue and net profit. The company reported a revenue growth of 15.6% year-over-year, driven by strong demand for its pharmaceutical products, particularly in the cardiovascular and anti-infective segments. Net profit saw an even more impressive rise, up by 23.4%, attributed to enhanced operational efficiencies and cost management strategies. Additionally, the board proposed a dividend of RMB 0.50 per share, reflecting confidence in the company's financial health and future prospects. This proposal is subject to shareholder approval at the upcoming annual general meeting. The company also highlighted its ongoing investments in research and development, aiming to expand its product portfolio and strengthen its market position both domestically and internationally.

Read the Full TipRanks Article at:
[ https://www.msn.com/en-us/money/top-stocks/tianjin-lisheng-pharmaceutical-reports-2024-financial-results-and-dividend-proposal/ar-AA1BlYkl ]

Publication Contributing Sources

Similar Business and Finance Publications